Cargando…
Risk of venous thromboembolism during the use of oral estrogen-progestogen hormone therapies in light of most recent research findings
Two important studies evaluating the safety profile of oral estrogen-progestogen hormonal therapies conducted in standard clinical practice with respect to the venous system were recently published. A large prospective controlled cohort study (PRO-E2) based on the non-inferiority design has shown th...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Termedia Publishing House
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9551365/ https://www.ncbi.nlm.nih.gov/pubmed/36254131 http://dx.doi.org/10.5114/pm.2022.119861 |